Gene · 4100
Papers1,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Trial watch: Dendritic cell (DC)-based immunotherapy for cancer. | Oncoimmunology | 2022 | 35800158 | PubTator, text mining | PubMed |
| Natural high-avidity T-cell receptor efficiently mediates regression of cancer/testis antigen 83 positive common solid cancers. | J Immunother Cancer | 2022 | 35798537 | PubTator, text mining | PubMed |
| Analysis of potential biomarkers of response to IL-12 therapy. | J Leukoc Biol | 2022 | 35790025 | PubTator, text mining | PubMed |
| Synergistic Therapeutic Effects of Low Dose Decitabine and NY-ESO-1 Specific TCR-T Cells for the Colorectal Cancer With Microsatellite Stability. | Front Oncol | 2022 | 35774131 | PubTator, text mining | PubMed |
| Clinicopathological assessment of cancer/testis antigens NY‑ESO‑1 and MAGE‑A4 in osteosarcoma. | Eur J Histochem | 2022 | 35736245 | PubTator, text mining | PubMed |
| Recent Progress on Therapeutic Vaccines for Breast Cancer. | Front Oncol | 2022 | 35734599 | PubTator, text mining | PubMed |
| Low Tumor Infiltrating Mast Cell Density Reveals Prognostic Benefit in Cervical Carcinoma. | Technol Cancer Res Treat | 2022 | 35730194 | PubTator, text mining | PubMed |
| TCR engineered T cells for solid tumor immunotherapy. | Exp Hematol Oncol | 2022 | 35725570 | PubTator, text mining | PubMed |
| Utility and Drawbacks of Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Lung Cancer. | Front Immunol | 2022 | 35720364 | PubTator, text mining | PubMed |
| The progress of peptide vaccine clinical trials in gynecologic oncology. | Hum Vaccin Immunother | 2022 | 35687860 | PubTator, text mining | PubMed |
| RAF1 promotes lymphatic metastasis of hypopharyngeal carcinoma via regulating LAGE1: an experimental research. | J Transl Med | 2022 | 35668458 | PubTator, text mining | PubMed |
| Epi-immunotherapy for cancers: rationales of epi-drugs in combination with immunotherapy and advances in clinical trials. | Cancer Commun (Lond) | 2022 | 35642676 | PubTator, text mining | PubMed |
| mRNA-based therapeutics: powerful and versatile tools to combat diseases. | Signal Transduct Target Ther | 2022 | 35597779 | PubTator, text mining | PubMed |
| Efficacy of autoantibodies combined with tumor markers in the detection of lung cancer. | J Clin Lab Anal | 2022 | 35596744 | PubTator, text mining | PubMed |
| Multifaceted regulation and functions of 53BP1 in NHEJ‑mediated DSB repair (Review). | Int J Mol Med | 2022 | 35583003 | PubTator, text mining | PubMed |
| Soluble HLA peptidome of pleural effusions is a valuable source for tumor antigens. | J Immunother Cancer | 2022 | 35580925 | PubTator, text mining | PubMed |
| The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines. | Cancer Treat Rev | 2022 | 35576777 | PubTator, text mining | PubMed |
| Multivariant Transcriptome Analysis Identifies Modules and Hub Genes Associated with Poor Outcomes in Newly Diagnosed Multiple Myeloma Patients. | Cancers (Basel) | 2022 | 35565356 | PubTator, text mining | PubMed |
| Development of Diagnosis Model for Early Lung Nodules Based on a Seven Autoantibodies Panel and Imaging Features. | Front Oncol | 2022 | 35530343 | PubTator, text mining | PubMed |
| Discovery and Structural Basis of the Selectivity of Potent Cyclic Peptide Inhibitors of MAGE-A4. | J Med Chem | 2022 | 35522528 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4100/papers?page=13